mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for MNAT1
Gene summary
Basic gene Info.Gene symbolMNAT1
Gene nameMNAT CDK-activating kinase assembly factor 1
SynonymsCAP35|MAT1|RNF66|TFB3
CytomapUCSC genome browser: 14q23
Type of geneprotein-coding
RefGenesNM_001177963.1,
NM_002431.3,
DescriptionCDK-activating kinase assembly factor MAT1CDK7/cyclin-H assembly factorRING finger protein 66RING finger protein MAT1cyclin G1 interacting proteincyclin-G1-interacting proteinmenage a trois 1 (CAK assembly factor)menage a trois homolog 1, cyclin H
Modification date20141207
dbXrefs MIM : 602659
HGNC : HGNC
Ensembl : ENSG00000020426
HPRD : 04042
Vega : OTTHUMG00000152340
ProteinUniProt: P51948
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_MNAT1
BioGPS: 4331
PathwayNCI Pathway Interaction Database: MNAT1
KEGG: MNAT1
REACTOME: MNAT1
Pathway Commons: MNAT1
ContextiHOP: MNAT1
ligand binding site mutation search in PubMed: MNAT1
UCL Cancer Institute: MNAT1
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006200ATP catabolic process9852112
GO:0006357regulation of transcription from RNA polymerase II promoter10801852
GO:0006366transcription from RNA polymerase II promoter9852112
GO:0006468protein phosphorylation9852112
GO:0045944positive regulation of transcription from RNA polymerase II promoter8692841


Top
Ligand binding site mutations for MNAT1

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
C31L30FHNSC1
C9R8WHNSC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for MNAT1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
C31L30F-1.0362268
C9R8W-0.75155062
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for MNAT1 from PDB

Top
Differential gene expression and gene-gene network for MNAT1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of MNAT1 and the right PPI network was created from samples without mutations in the LBS of MNAT1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for MNAT1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for MNAT1
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of MNAT1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
ZNZINC(2+)1g25AC9 C31


Top
Conservation information for LBS of MNAT1
Multiple alignments for P51948 in multiple species
LBSAA sequence# speciesSpecies
C26MVNV-CGHTLC2Homo sapiens, Mus musculus
C26LINPECYHKMC1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
C26LVNPECYHRIC1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
C26LINPECYHKIC1Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37)
C26LVNPECYHKIC1Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056)
C31CGHTLCESCVD2Homo sapiens, Mus musculus
C31CYHKICESCVD2Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056)
C31CYHKMCESCVD1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
C31CYHRICESCVD1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
C34TLCESCVDLLF2Homo sapiens, Mus musculus
C34KICESCVDRIF2Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056)
C34KMCESCVDRIF1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
C34RICESCVDRIF1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
C46RGAGNCP--EC2Homo sapiens, Mus musculus
C46LGPAQCPYEGC2Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056)
C46TGPAQCPTPGC1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
C46LGPAQCPYKGC1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
C49CP--ECGTPLR2Homo sapiens, Mus musculus
C49CPYEGCDKILR2Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056)
C49CPTPGCNKILR1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
C49CPYKGCDKILR1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
C6DM---CPICKT3Saccharomyces cerevisiae (strain ATCC 204508 / S288c), Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056)
C6-----CPRCKT2Homo sapiens, Mus musculus
C6KVDEKCPLCQA1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
C9--CPICKTDRY3Saccharomyces cerevisiae (strain ATCC 204508 / S288c), Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056)
C9--CPRCKTTKY2Homo sapiens, Mus musculus
C9EKCPLCQADRY1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
H28NV-CGHTLCES2Homo sapiens, Mus musculus
H28NPECYHKICES2Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37), Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056)
H28NPECYHKMCES1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
H28NPECYHRICES1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas